Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein

被引:81
作者
Chanvorachote, P
Nimmannit, U [1 ]
Wang, LY
Stehlik, C
Lu, B
Azad, N
Rojanasakul, Y
机构
[1] Chulalongkorn Univ, Pharmaceut Technol Int Program, Bangkok 10330, Thailand
[2] W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA
[3] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA
[4] NIOSH, Pathol & Physiol Res Branch, Morgantown, WV 26505 USA
关键词
D O I
10.1074/jbc.M510080200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stimulation of cell surface Fas ( CD95) results in recruitment of cytoplasmic proteins and activation of caspase-8, which in turn activates downstream effector caspases leading to programmed cell death. Nitric oxide ( NO) plays a key role in the regulation of apoptosis, but its role in Fas-induced cell death and the underlying mechanism are largely unknown. Here we show that stimulation of the Fas receptor by its ligand ( FasL) results in rapid generation of NO and concomitant decrease in cellular FLICE inhibitory protein ( FLIP) expression without significant effect on Fas and Fas-associated death domain ( FADD) adapter protein levels. FLIP down-regulation as well as caspase-8 activation and apoptosis induced by FasL were all inhibited by the NO-liberating agent sodium nitroprusside and dipropylenetriamine NONOate, whereas the NO synthase inhibitor aminoguanidine and NO scavenger 2-(4-carboxyphenyl)4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide ( PTIO) had opposite effects, indicating an anti-apoptotic role of NO in the Fas signaling process. FasL-induced down-regulation of FLIP is mediated by a ubiquitin-proteasome pathway that is negatively regulated by NO. S-nitrosylation of FLIP is an important mechanism rendering FLIP resistant to ubiquitination and proteasomal degradation by FasL. Deletion analysis shows that the caspase-like domain of FLIP is a key target for S-nitrosylation by NO, and mutations of its cysteine 254 and cysteine 259 residues completely inhibit S-nitrosylation, leading to increased ubiquitination and proteasomal degradation of FLIP. These findings indicate a novel pathway for NO regulation of FLIP that provides a key mechanism for apoptosis regulation and a potential new target for intervention in death receptor-associated diseases.
引用
收藏
页码:42044 / 42050
页数:7
相关论文
共 64 条
[1]   Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro [J].
Abedini, MR ;
Qiu, Q ;
Yan, XJ ;
Tsang, BK .
ONCOGENE, 2004, 23 (42) :6997-7004
[2]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[3]   Nitric oxide induces apoptosis via hydrogen peroxide, but necrosis via energy and thiol depletion [J].
Borutaite, V ;
Brown, GC .
FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 (11) :1457-1468
[4]   Activation of the NF-κB pathway by Caspase 8 and its homologs [J].
Chaudhary, PM ;
Eby, MT ;
Jasmin, A ;
Kumar, A ;
Liu, L ;
Hood, L .
ONCOGENE, 2000, 19 (39) :4451-4460
[5]   Cross-talk between Fas/Fas ligand system and nitric oxide in the pathway subserving granulosa cell apoptosis: A possible regulatory mechanism for ovarian follicle atresia [J].
Chen, QM ;
Yano, T ;
Matsumi, H ;
Osuga, Y ;
Yano, N ;
Xu, JP ;
Wada, O ;
Koga, K ;
Fujiwara, T ;
Kugu, K ;
Taketani, Y .
ENDOCRINOLOGY, 2005, 146 (02) :808-815
[6]   The role of Fas in autoimmune diabetes [J].
Chervonsky, AV ;
Wang, Y ;
Wong, FS ;
Visintin, I ;
Flavell, RA ;
Janeway, CA ;
Matis, LA .
CELL, 1997, 89 (01) :17-24
[7]   INTERLEUKIN-1-BETA SUPPRESSES APOPTOSIS IN RAT OVARIAN FOLLICLES BY INCREASING NITRIC-OXIDE PRODUCTION [J].
CHUN, SY ;
EISENHAUER, KM ;
KUBO, M ;
HSUEH, AJW .
ENDOCRINOLOGY, 1995, 136 (07) :3120-3127
[8]   Nitric oxide as a bioregulator of apoptosis [J].
Chung, HT ;
Pae, HO ;
Choi, BM ;
Billiar, TR ;
Kim, YM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (05) :1075-1079
[9]   The ubiquitin-proteasome pathway: on protein death and cell life [J].
Ciechanover, A .
EMBO JOURNAL, 1998, 17 (24) :7151-7160
[10]   Novel effects of nitric oxide [J].
Davis, KL ;
Martin, E ;
Turko, IV ;
Murad, F .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :203-236